The new drug is a 'modernized' version of tetracycline, designed to address antibiotic resistance, but its clinical role isn't yet clear.
Merck announced yesterday that the US Food and Drug Administration has accepted for priority review a New Drug Application (NDA) for the combination of relebactam and imipenem/cilastatin and a supplemental NDA for Zerbaxa (ceftolozane and tazobactam).
Today Saudi Arabia's Ministry of Health (MOH) reported two new MERS-CoV cases, both in Wadi Al Dawasir, a town in south-central Saudi Arabia.
In an update to its epidemiologic week 5 report, the MOH said the patients were a 44-year-old man and a 62-year-old women, both hospitalized for their MERS-CoV (Middle East respiratory syndrome coronavirus) infections.
Flu levels are rising in some parts of the country, but nationally activity is still low, the US Centers for Disease Control and Prevention (CDC) said today in its latest weekly flu update.
About 61% of kids in children's hospitals got guideline-concordant therapy, compared with only 27% in non-children's hospitals.
Neisseria gonorrhea and carbapenamase-producing Enterobacteriaceae (CPE) remain the most commonly reported organisms with resistance to critical antibiotics in Australia, according to a report yesterday by the Australian Commission on Safety and Quality in Health Care (the Commission).
The UK Department of Health and Social Care (DHSC) yesterday announced the launch of a £10 million ($13 million) research competition to fund innovative efforts to combat antimicrobial resistance (AMR).
The death toll for a Nipah virus outbreak in India's Kerala state now stands at 10, after at least 12 more people have been diagnosed as having the deadly virus, according to a Reuters report today.
Reuters said an additional nine people are being treated for infections with supportive care. Nipah virus is most commonly spread by fruit bats, and presents with severe, flu-like symptoms.
The United Kingdom's National Institute for Health and Care Excellence (NICE) today issued draft guidance for the treatment of urinary tract infections (UTIs).
In a speech at the annual meeting of the Massachusetts Medical Society on Apr 27, philanthropist and Microsoft cofounder Bill Gates announced the launch of a $12 million Grand Challenge to speed the development of a universal flu vaccine.
